Authors: Kosmas, C Tsavaris, NB Malamos, NA Vadiaka, M Koufos, C

Citation: C. Kosmas et al., Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer, J CL ONCOL, 19(1), 2001, pp. 119-126

Authors: Tsavaris, N Kosmas, C Vadiaka, M Kontos, A Katsorida, M Dimitrakopoulos, A Zerai, A Koufos, C

Citation: N. Tsavaris et al., Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study, J EXP CL C, 20(1), 2001, pp. 29-34

Authors: Tsavaris, N Kosmas, C Vadiaka, W Kanelopoulos, P Kontos, A Katsorida, M Agelopoulou, A Vrizidis, N Fotia, M Papoutsis, K Koufos, C

Citation: N. Tsavaris et al., Ondansentron and dexamethasone treatment with different dosing schedules (24 versus 32 mg) in patients with non-small-cell lung cancer under cisplatin-based chemotherapy: A randomized study, CHEMOTHERA, 46(5), 2000, pp. 364-370

Authors: Tsavaris, NB Koufos, C Katsikas, M Dimitrakopoulos, A Athanasiou, E Linardaki, G

Citation: Nb. Tsavaris et al., Antiemetic prophylaxis with ondansetron and methylprednisolone vs metoclopramide and methylprednisolone in mild and moderately emetogenic chemotherapy, J PAIN SYMP, 18(3), 1999, pp. 218-222

Authors: Koufos, C Tsavaris, N Travlou, A

Citation: C. Koufos et al., Unusual development of an abdominal neoplasm in a patient with Maffucci's syndrome, PANMIN MED, 40(4), 1998, pp. 338-342